First drug to slow Alzheimer’s too costly for NHS

First drug to slow Alzheimer’s too costly for NHS

Health assessment body NICE says the benefits “are too small to justify the costs”.Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.